Search

everythinglearnresearchcommunity

for

Search:↓

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Two patients with porphyria cutanea tarda experienced their grey hair turning dark again.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Higher minoxidil dose helps hair growth in non-responders without side effects.

The document discusses various challenging skin conditions and their treatments.

Chemotherapy and radiation therapy cause skin and hair damage by altering gene expression and signaling pathways.

Early and late matrix progenitors in hair follicles create different cell layers, with early ones forming the companion layer and later ones forming the inner root sheath and hair shaft.

Sweat glands and hair follicles are determined by opposing signals, with BMPs promoting sweat glands and blocking BMPs leading to hair follicles.

Researchers improved a method to study individual cells in newborn mouse skin and found a way to assess the severity of a skin condition in humans.

Dr. Dzubow concluded that careful attention to detail is crucial for the success of Mohs surgery in treating skin cancer.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Nested PCR can reliably identify fungal infections when traditional methods fail.

Antiandrogen therapy helps treat genetic hair loss.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

SHBG may be a useful early indicator and treatment target for PCOS.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.